Zusammenfassung
Dyspnoe ist eines der häufigsten Leitsymptome, das zu einem Arztbesuch führt. Die Ursachen der Dyspnoe sind vielfältig und betreffen nicht nur Erkrankungen des kardiorespiratorischen Systems, sondern auch metabolische, neuromuskuläre und andere Störungen. Für die Diagnostik und die notwendigen Therapiemaßnahmen ist es zunächst von großer Bedeutung, zwischen akuter und chronischer Atemnot zu unterscheiden. Der Beitrag befasst sich neben den Differenzialdiagnosen, der Diagnostik und der Therapie der Dyspnoe auch mit der Pathophysiologie und der Problematik der Objektivierbarkeit dieses Symptoms.
Abstract
Dyspnea is one of the most frequent leading symptoms that prompts patients to seek medical advice. The causes of dyspnea are multifaceted and affect not only diseases of the cardiorespiratory system but also metabolic, neuromuscular, and other disorders. It is first essential to differentiate between acute and chronic respiratory depression for the diagnostic work-up to initiate the necessary therapeutic measures. This article addresses the differential diagnoses, diagnostics, and treatment of dyspnea as well as the pathophysiology and problems involved in the ability to objectify this symptom.
Literatur
Ando T, Ogawa K, Yamaki K et al. (1996) Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases. Chest 110:462–468
ATS (1999) Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 159:321–340
Banzett RB, Lansing RW, Brown R et al. (1990) „Air hunger“ from increased PCO2 persists after complete neuromuscular block in humans. Respir Physiol 81:1–17
Banzett RB, Mulnier HE, Murphy K et al. (2000) Breathlessness in humans activates insular cortex. Neuroreport 11:2117–2120
Borg G (1970) Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 2:92–98
Bradley BL, Garner AE, Billiu D et al. (1978) Oxygen-assisted exercise in chronic obstructive lung disease. The effect on exercise capacity and arterial blood gas tensions. Am Rev Respir Dis 118:239–243
Bruera E, de Stoutz N, Velasco-Leiva A et al. (1993) Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet 342:13–14
Bye PT, Esau SA, Levy RD et al. (1985) Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. Am Rev Respir Dis 132:236–240
Cabanes L, Richaud-Thiriez B, Fulla Y et al. (2001) Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 120:2047–2050
Chonan T, Mulholland MB, Cherniack NS, Altose MD (1987) Effects of voluntary constraining of thoracic displacement during hypercapnia. J Appl Physiol 63:1822–1828
Chonan T, Mulholland MB, Leitner J et al. (1990) Sensation of dyspnea during hypercapnia, exercise, and voluntary hyperventilation. J Appl Physiol 68:2100–2106
Dao Q, Krishnaswamy P, Kazanegra R et al. (2001) Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37:379–385
Dudgeon DJ, Lertzman M (1998) Dyspnea in the advanced cancer patient. J Pain Symptom Manage 16:212–219
Elliott MW, Adams L, Cockcroft A et al. (1991) The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 144:826–832
Eyzaguirre C, Zapata P (1984) Perspectives in carotid body research. J Appl Physiol 57:931–957
Fletcher CM, Elmes PC, Fairbairn AS, Wood CH (1959) The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 5147:257–266
Grazzini M, Ottanelli R, Duranti R et al. (2002) Measures of perception of bronchoconstriction and clinical and functional data are not interrelated in asthma. Respiration 69:496–501
Harris-Eze AO, Sridhar G, Clemens RE et al. (1994) Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 150:1616–1622
Johnson MA, Woodcock AA, Geddes DM (1983) Dihydrocodeine for breathlessness in „pink puffers“. Br Med J (Clin Res Ed) 286:675–677
Leblanc P, Bowie DM, Summers E et al. (1986) Breathlessness and exercise in patients with cardiorespiratory disease. Am Rev Respir Dis 133:21–25
Leung R, Hill P, Burdon J (1996) Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease. Thorax 51:596–600
Mahler DA, Rosiello RA, Harver A et al. (1987) Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 135:1229–1233
Mahler DA, Harver A, Lentine T et al. (1996) Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 154:1357–1363
Maisel A (2001) B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 19:557–571
Maisel AS, Krishnaswamy P, Nowak RM et al. (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167
Manning H (1998) Invited editorial on „Effects of chest wall vibration on breathlessness during hypercapnic ventilatory response“. J Appl Physiol 84:1485–1486
Manning HL, Molinary EJ, Leiter JC (1995) Effect of inspiratory flow rate on respiratory sensation and pattern of breathing. Am J Respir Crit Care Med 151:751–757
Manning HL, Shea SA, Schwartzstein RM et al. (1992) Reduced tidal volume increases ‚air hunger‘ at fixed PCO2 in ventilated quadriplegics. Respir Physiol 90:19–30
McCullough PA, Nowak RM, McCord J et al. (2002) B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106:416–422
McGavin CR, Artvinli M, Naoe H, McHardy GJ (1978) Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 2:241–243
Morrison LK, Harrison A, Krishnaswamy P et al. (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202–209
Moy ML, Woodrow Weiss J, Sparrow D et al. (2000) Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med 162:451–455
Nolte D (1985) Asthma, Atemnot, Atemfunktion. Gedon & Reuss, München, S 87
O’Donnell DE, Webb KA (1993) Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 148:1351–1357
O’Donnell DE, Bertley JC, Chau LK, Webb KA (1997) Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 155:109–115
Peiffer C, Poline JB, Thivard L et al. (2001) Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 163:951–957
Pratter MR, Curley FJ, Dubois J, Irwin RS (1989) Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 149:2277–2282
Rice KL, Kronenberg RS, Hedemark LL, Niewoehner DE (1987) Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Br J Dis Chest 81:287–292
Rochester DF (1993) Respiratory muscles and ventilatory failure: 1993 perspective. Am J Med Sci 305:394–402
Rubinfeld AR, Pain MC (1976) Perception of asthma. Lancet 1:882–884
Schwartzstein RM, Simon PM, Weiss JW et al. (1989) Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis 139:1231–1237
Seamens CM, Wrenn K (1995) Breathlessness. Strategies aimed at identifying and treating the cause of dyspnea. Postgrad Med 98:215–216, 219–222, 225–217
Simon PM, Schwartzstein RM, Weiss JW et al. (1990) Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 142:1009–1014
Stein DA, Bradley BL, Miller WC (1982) Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest 81:6–10
Swinburn CR, Wakefield JM, Jones PW (1984) Relationship between ventilation and breathlessness during exercise in chronic obstructive airways disease is not altered by prevention of hypoxaemia. Clin Sci (Lond) 67:515–519
Taguchi O, Kikuchi Y, Hida W et al. (1991) Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 71:2183–2190
Wasserman K, Casaburi R (1988) Dyspnea: physiological and pathophysiological mechanisms. Annu Rev Med 39:503–515
Wilson RC, Jones PW (1991) Differentiation between the intensity of breathlessness and the distress it evokes in normal subjects during exercise. Clin Sci (Lond) 80:65–70
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pfeifer, M. Dyspnoe. Pneumologe 2, 177–187 (2005). https://doi.org/10.1007/s10405-005-0044-1
Issue Date:
DOI: https://doi.org/10.1007/s10405-005-0044-1